CD274 and endometrial cancer: In the multi-cohort phase Ib trial, KEYNOTE-028 (NCT02054806), 24 endometrial cancer patients with locally advanced or metastatic PD-L1 positive (>1%) endometrial cancer were treated with pembrolizumab monotherapy.